249 related articles for article (PubMed ID: 25634026)
1. Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.
Weitmann K; Hirt C; Schwarz S; Rabkin C; Dölken G; Hoffmann W
Cancer Causes Control; 2015 Mar; 26(3):455-65. PubMed ID: 25634026
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study.
Lu Y; Wang SS; Sullivan-Halley J; Chang ET; Clarke CA; Henderson KD; Ma H; Duan L; Lacey JV; Deapen D; Bernstein L
Int J Cancer; 2011 Aug; 129(4):974-82. PubMed ID: 20957632
[TBL] [Abstract][Full Text] [Related]
3. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
4. Menopausal hormone therapy and gallbladder disease: the Study of Health in Pomerania (SHIP).
Schwarz S; Völzke H; Baumeister SE; Hampe J; Dören M
Clin Endocrinol (Oxf); 2007 Jul; 67(1):51-9. PubMed ID: 17437513
[TBL] [Abstract][Full Text] [Related]
5. Oral Contraceptive and Menopausal Hormone Therapy Use and Risk of Pituitary Adenoma: Cohort and Case-Control Analyses.
Cote DJ; Kilgallon JL; Nawabi NLA; Dawood HY; Smith TR; Kaiser UB; Laws ER; Manson JE; Stampfer MJ
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1402-e1412. PubMed ID: 34865056
[TBL] [Abstract][Full Text] [Related]
6. Gynaecological health care utilization and use of sex hormones--the study of Health in Pomerania.
Schwarz S; Völzke H; Alte D; Hoffmann W; John U; Dören M
Hum Reprod; 2005 Oct; 20(10):2916-22. PubMed ID: 15980010
[TBL] [Abstract][Full Text] [Related]
7. Female Estrogen-Related Factors and Incidence of Basal Cell Carcinoma in a Nationwide US Cohort.
Cahoon EK; Kitahara CM; Ntowe E; Bowen EM; Doody MM; Alexander BH; Lee T; Little MP; Linet MS; Freedman DM
J Clin Oncol; 2015 Dec; 33(34):4058-65. PubMed ID: 26527779
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
[TBL] [Abstract][Full Text] [Related]
9. Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.
Velentzis LS; Banks E; Sitas F; Salagame U; Tan EH; Canfell K
PLoS One; 2016; 11(3):e0146494. PubMed ID: 27008039
[TBL] [Abstract][Full Text] [Related]
10. Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use.
Lee JS; Bracci PM; Holly EA
Am J Epidemiol; 2008 Aug; 168(3):278-88. PubMed ID: 18550561
[TBL] [Abstract][Full Text] [Related]
11. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones.
La Vecchia C; Ron E; Franceschi S; Dal Maso L; Mark SD; Chatenoud L; Braga C; Preston-Martin S; McTiernan A; Kolonel L; Mabuchi K; Jin F; Wingren G; Galanti MR; Hallquist A; Lund E; Levi F; Linos D; Negri E
Cancer Causes Control; 1999 Apr; 10(2):157-66. PubMed ID: 10231164
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study.
Shilbayeh S
Osteoporos Int; 2003 Nov; 14(11):929-40. PubMed ID: 14530908
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
14. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
[TBL] [Abstract][Full Text] [Related]
15. Menopausal hormone therapy, oral contraceptives and risk of chronic low back pain: the HUNT Study.
Heuch I; Heuch I; Hagen K; Storheim K; Zwart JA
BMC Musculoskelet Disord; 2023 Jan; 24(1):84. PubMed ID: 36721124
[TBL] [Abstract][Full Text] [Related]
16. Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study.
Velentzis LS; Egger S; Banks E; Canfell K
PLoS One; 2021; 16(8):e0253725. PubMed ID: 34379634
[TBL] [Abstract][Full Text] [Related]
17. Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.
Du Y; Dören M; Melchert HU; Scheidt-Nave C; Knopf H
BMC Womens Health; 2007 Oct; 7():19. PubMed ID: 17945013
[TBL] [Abstract][Full Text] [Related]
18. Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.
Park SY; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L
Int J Cancer; 2016 Sep; 139(6):1241-50. PubMed ID: 27137137
[TBL] [Abstract][Full Text] [Related]
19. Menopausal hormone therapy is associated with having high blood pressure in postmenopausal women: observational cohort study.
Chiu CL; Lujic S; Thornton C; O'Loughlin A; Makris A; Hennessy A; Lind JM
PLoS One; 2012; 7(7):e40260. PubMed ID: 22808129
[TBL] [Abstract][Full Text] [Related]
20. Menopause hormone therapy and sarcodynapenia: the Canadian Longitudinal Study on Aging.
Câmara SMA; Macêdo PRS; Velez MP
Menopause; 2023 Mar; 30(3):254-259. PubMed ID: 36729434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
